MYC is sufficient to generate mid-life high-grade serous ovarian and uterine serous carcinomas in a p53-R270H mouse model.
Blackman A, Rees AC, Bowers RR, Jones CM, Vaena SG, Clark MA, Carter S, Villamor ED, Evans D, Emanuel AJ, Fullbright G, Long DT, Spruill L, Romeo MJ, Helke KL, Delaney JR.
Blackman A, et al. Among authors: rees ac.
bioRxiv [Preprint]. 2024 Jan 29:2024.01.24.576924. doi: 10.1101/2024.01.24.576924.
bioRxiv. 2024.
PMID: 38352443
Free PMC article.
Preprint.